Overview
Precision Instruments

MANI,INC.

MANI, INC. is a Japanese manufacturer of precision medical and dental devices, producing three core product lines: Surgical products (skin staplers, ophthalmic knives, vitreous forceps, and suture needles with thread), Eyeless/Eyed needle-related products (atraumatic suture needles supplied as materials to suture manufacturers), and Dental products (endodontic root canal instruments including reamers/files and NiTi rotary files, rotary cutting instruments such as diamond and carbide burs, and dental restorative materials). The company operates manufacturing facilities in Japan, Vietnam, and Myanmar, with sales subsidiaries in China, India, Germany, and the United States. MANI differentiates itself through proprietary manufacturing technologies and a commitment to high-precision quality in minimally-sized medical instruments.

Market Cap
¥151B
US$963M
EV
¥124B
US$793M
Stock¥1,534▼-0.26%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
10.0
x
LTM EV/EBIT
12.5
x
LTM PER
20.9
x
LTM PBR
2.6
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-19.9%pt
1001
Oct 24, 25 – Oct 23, 26StockTOPIX
1Jul 16, 26Q3 FY2026/08 earnings announced
MC → EV Bridge
151BUS$963MMarket Cap0.08BUS$0.52M+ Debt26.5BUS$169M− Cash0.30BUS$1.88M− Inv. Sec.124BUS$793MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
20.4US$130M'22/824.5US$156M'23/828.5US$182M'24/830.0US$191M'25/833.0US$211M'26/8
EBITDA 5Y (¥B)
7.83US$49.9M'22/89.16US$58.4M'23/810.7US$68.0M'24/810.7US$68.0M'25/812.4US$79.0M'26/8
Net Income 5Y (¥B)
5.29US$33.7M'22/85.95US$38.0M'23/86.29US$40.1M'24/84.64US$29.6M'25/87.24US$46.2M'26/8
Capital Structure
100%
EquityD/E 0.00xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
23.1US$147M0.12US$0.75M'22/825.8US$164M0.06US$0.37M'23/821.9US$140M0.08US$0.53M'24/818.5US$118M0.08US$0.48M'25/826.8US$171M0.08US$0.52M'26/8
Shareholders
Top 10 hold 45.9%
1
The Master Trust Bank of Japan, Ltd. (Trust Account)
12.33%
2
Manix Co., Ltd.
10.76%
3
Matsutani Giken Co., Ltd.
5.16%
4
Custody Bank of Japan, Ltd. (Trust Account)
4.17%
5
Manny Matsutani Medical Scholarship Foundation (Public Interest Foundation)
3.25%
6
Kanji MATSUTANI
2.14%
7
Nomura Trust and Banking Co., Ltd. (Investment Trust Account)
2.12%
8
Shoko Co., Ltd.
2.08%
9
Masamitsu MATSUTANI
2.07%
10
Masaaki MATSUTANI
1.82%
Management
7 officers
Shinya WATANABE
Director
Apr 1982 Joined Hitachi, Ltd. Mar 2009 Director and Chief Strategist, Hitachi Global Storage Technologies (USA) Apr 2012 Executive Managing Director, Hitachi, Ltd.; CSO and CIO, Information & Telecommunication Systems Company Apr 2014 Executive Managing Director, Hitachi, Ltd.; President, Hitachi America (USA) and Chairman, Hitachi Consulting (USA) Apr 2015 Executive Managing Director, Hitachi, Ltd.; President, Healthcare Company Jun 2017 Chairman, Japan Federation of Medical Devices Associations Apr 2019 Executive Managing Director, Hitachi, Ltd.; CISO and General Manager, Smart Transformation Strengthening Headquarters Jun 2020 Director and Representative Executive Vice President, COO & CIO, Miraca Holdings Inc. (current H.U. Group Holdings, Inc.) Nov 2022 Outside Director of the Company Jan 2023 Outside Director, CROSS SYNC Inc. Aug 2023 Member, Review Council, Japan Agency for Medical Research and Development, Cabinet Office (current) Apr 2025 Chairman of the Board of Directors of the Company Visiting Professor, Healthcare Data Science Course, Graduate School of Medicine, Ehime University (current) Director and Representative Executive Officer, President of the Company (current) Advisor, Japan Institute for Health Security (current)
1958-01-31
Kazuo TAKAHASHI
Director
Mar 1978 Joined Hogy Co., Ltd. (current Hogy Medical Co., Ltd.) Jun 2009 Director and General Manager, Corporate Planning and Product Management Departments, Hogy Co., Ltd. Aug 2013 Advisor to the Company Nov 2014 Executive Officer of the Company Nov 2016 Managing Executive Officer of the Company Nov 2018 Director of the Company (current) Executive Vice President of the Company Nov 2020 Representative Executive Vice President of the Company Nov 2021 Executive Vice President of the Company May 2025 CFO and General Manager, Corporate Planning Office of the Company Sep 2025 Assistant to the President (Special Assignments) and CRO of the Company (current) Full-time Senior Advisor and Director of the Company (current)
1955-01-17
Hisahide TAKAI
Director
Apr 1977 Joined The Nippon Fudosan Bank, Ltd. (formerly Nippon Credit Bank, Ltd.; current Aozora Bank, Ltd.) Oct 2006 Advisor to the Company Nov 2006 Executive Officer and General Manager, Corporate Planning Department of the Company Nov 2007 Managing Executive Officer of the Company Nov 2008 Senior Managing Executive Officer of the Company Nov 2011 Executive Vice President of the Company Nov 2013 Director of the Company (current) Representative Executive Officer, President of the Company Nov 2020 Chairman of the Executive Officers of the Company Nov 2021 Vice Chairman of the Board of Directors of the Company
1952-07-20
Yosuke MITSUSADA
Chairman of the Board of Directors
Apr 1986 Joined Nippon Credit Bank, Ltd. (current Aozora Bank, Ltd.) Oct 1999 Joined Unison Capital Co., Ltd. May 2002 Statutory Auditor, Tohato Co., Ltd. Jul 2002 Director, Borsa Yugen Kaisha (current) Mar 2005 Joined Asuka Asset Management Limited (current Aizawa Asset Management Co., Ltd.) Apr 2007 Associate Professor, Faculty of Business Administration, Sangyo Noritsu University Apr 2012 Professor, Faculty of Business Administration, Sangyo Noritsu University (current) Jul 2013 Joined Asuka Asset Management Co., Ltd. (current Aizawa Asset Management Co., Ltd.) Aug 2013 Director and Founding Partner, Asuka Corporate Advisory Co., Ltd. (current) Nov 2016 Outside Director, Yume no Machi Souzou Iinkai Co., Ltd. (current Demae-can Co., Ltd.) Jun 2019 Outside Director, Phiz Co., Ltd. (current Phiz Holdings Co., Ltd.) Jun 2021 Outside Director, Kyodo Printing Co., Ltd. (current) Nov 2023 Outside Director of the Company (current) Jul 2024 Chairman of the Board of Directors of the Company (current)
1963-12-24
Yukio MATSUI
Director
Apr 1984 Joined Fujisawa Pharmaceutical Co., Ltd. (current Astellas Pharma Inc.) Apr 2012 General Manager, Marketing & Business Management, Asia & Oceania, Astellas Pharma Inc. Apr 2015 Executive Officer, Head of Global Marketing Strategy, Astellas Pharma Inc. Apr 2016 Executive Officer, Head of Europe, Middle East & Africa Business, Astellas Pharma Inc. Jul 2018 Senior Managing Executive Officer, Head of Sales (Chief Commercial Officer), Astellas Pharma Inc. Apr 2024 Operating Advisor, Value Accelerator, Goldman Sachs Asset Management (current) Advisor, Toho Holdings Co., Ltd. (current) Nov 2024 Outside Director of the Company (current)
1962-01-24
Hiroyuki SASA
Director
Apr 1982 Joined Olympus Optical Co., Ltd. (current Olympus Corporation) Jun 2007 Executive Officer, Olympus Corporation Jun 2007 Director, Olympus Medical Systems Corp. Mar 2012 Assistant to the President and Assistant to the President for Information & Communications Business, Olympus Corporation Apr 2012 Representative Director, President and Executive Officer, Olympus Corporation Apr 2019 Director, Olympus Corporation Jun 2020 Outside Director, Kyosan Electric Mfg. Co., Ltd. (current) Jun 2022 Outside Director, Kanematsu Corporation (current) Jun 2023 Outside Director, Amada Co., Ltd. (current) Nov 2025 Outside Director of the Company (current)
1955-09-14
Nao TSUCHIYA
Director
Oct 2003 Registered with Daiichi Tokyo Bar Association; joined Hayabusa International Law Office (current Hayabusa Asuka Law Office) Jan 2012 Partner, Hayabusa Asuka Law Office Jun 2012 Outside Corporate Auditor, Seavon Co., Ltd. Nov 2014 Partner, PwC Legal Japan May 2016 Joined Lac Co., Ltd. Nov 2016 Executive Officer and General Manager, Legal Department, Lac Co., Ltd. Jun 2018 Outside Director, Meiko Electronics Co., Ltd. (current) Jun 2020 Part-time Director, Lac Co., Ltd. Jul 2020 Joined Yahoo Japan Corporation (current LY Corporation) Oct 2020 General Manager, Legal Division, Legal Headquarters, Yahoo Japan Corporation Apr 2023 Executive Officer, Head of Legal Headquarters, Yahoo Japan Corporation Apr 2024 Executive Officer, Head of Legal Headquarters, LY Corporation Oct 2025 Executive Officer, Lead of Legal & Corporate Business Unit, LY Corporation (current) Nov 2025 Outside Director of the Company (current)
1973-10-23
Large Shareholding Reports
First Sentier Investors (Hong Kong) Limited
2025-12-01
2.47%
First Sentier Investors (UK) IM Limited
2025-11-04
2.49%→3.55%
First Sentier Investors (UK) IM Limited
2025-08-04
1.31%→2.49%
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-10-15
Full-Year Earnings Flash
FY ending Aug 2026
TDnet
2026-07-15
Q3 Earnings Flash
FY ending Aug 2026
EDINET
2026-04-14
Semi-Annual Securities Report
Period: Sep 2025 – Aug 2026
TDnet
2026-01-14
Q1 Earnings Flash
FY ending Aug 2026
EDINET
2025-12-01
Large Shareholding Report
EDINET
2025-11-18
Annual Securities Report
Period: Sep 2024 – Aug 2025
EDINET
2025-11-04
Large Shareholding Report
EDINET
2025-08-04
Large Shareholding Report
TDnet
2025-07-09
Q3 Earnings Flash
FY ending Aug 2025
EDINET
2025-04-11
Semi-Annual Securities Report
Period: Sep 2024 – Aug 2025
TDnet
2025-01-14
Q1 Earnings Flash
FY ending Aug 2025
TDnet
2025-01-08
Q1 Earnings Flash
FY ending Aug 2025
EDINETAmended
2024-12-03
Amended Annual Securities Report
Period: Sep 2023 – Aug 2024
EDINET
2024-11-26
Annual Securities Report
Period: Sep 2023 – Aug 2024
EDINET
2024-07-12
Quarterly Securities Report
Period: Mar 2024 – May 2024
EDINET
2024-04-12
Quarterly Securities Report
Period: Dec 2023 – Feb 2024
EDINET
2024-01-12
Quarterly Securities Report
Period: Sep 2023 – Nov 2023
EDINET
2023-11-22
Annual Securities Report
Period: Sep 2022 – Aug 2023
EDINET
2023-07-14
Quarterly Securities Report
Period: Mar 2023 – May 2023
EDINET
2023-04-14
Quarterly Securities Report
Period: Dec 2022 – Feb 2023
EDINET
2023-01-13
Quarterly Securities Report
Period: Sep 2022 – Nov 2022
EDINET
2022-11-25
Annual Securities Report
EDINET
2022-07-15
Quarterly Securities Report
EDINET
2022-04-14
Quarterly Securities Report
EDINET
2022-01-14
Quarterly Securities Report
EDINETAmended
2021-12-27
Amended Annual Securities Report
EDINETAmended
2021-12-27
Amended Annual Securities Report
EDINETAmended
2021-12-27
Amended Annual Securities Report
EDINET
2021-11-25
Annual Securities Report
EDINET
2021-07-14
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →